EUVIMEDEUVIMED entdecken
Open Access

B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine

Mengze Lyu iD, Gregory F Sonnenberg iD

Journal of Experimental Medicine · 01.06.2026 · 223 (6)

DOI: 10.1084/jem.20251094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.04.2026. Verfasst von Mengze Lyu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Immune Tolerance, Nuclear Receptor Subfamily 1, Group F, Member 3, B7-1 Antigen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T (Treg) cells that recognize dietary- or microbiota-derived antigens express RORγt and are essential for immune tolerance in the intestine. A recent paradigm shift found these cells require major histocompatibility complex class II (MHCII) on RORγt+ antigen-presenting cells (APCs) rather than conventional dendritic cells (cDCs) for signal one. Here, we evaluate signal two and unexpectedly find that costimulatory molecules B7-1 (CD80) and B7-2 (CD86) antagonize the generation of microbiota-specific RORγt+ Treg cells. Gain-of-function or loss-of-function therapeutics targeting B7 via CTLA-4 exert reciprocal effects on the generation of microbiota-specific RORγt+ Treg cells. This axis was independent of B7 on RORγt+ APCs but required MHCII on this cell type. Finally, CTLA4-Ig treatment restores microbiota-specific RORγt+ Treg cell generation and protects from experimental intestinal inflammation induced by pathobiont colonization with IL-10R signaling blockade. These results define that RORγt+ Treg cells are uniquely restrained by B7 costimulation, while CTLA4-Ig enhances immune tolerance in the intestine when acting cooperatively with RORγt+ APCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryImmune ToleranceNuclear Receptor Subfamily 1, Group F, Member 3B7-1 AntigenB7-2 AntigenIntestinesAnimalsMiceCTLA-4 AntigenMice, Inbred C57BLAbataceptAntigen-Presenting CellsDendritic Cells

Substanzen

Nuclear Receptor Subfamily 1, Group F, Member 3B7-1 AntigenB7-2 AntigenCTLA-4 AntigenAbatacept

Autor:innen und Institutionen

  • Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology & Hepatology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Department of Microbiology & Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University , New York, NY, USA.

ORCID-Profile: Mengze Lyu, Gregory F Sonnenberg

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • Dalton Family Foundation
  • Meyer Cancer Center Collaborative Research Initiative
  • Burroughs Wellcome Fund
  • Linda and Glenn Greenberg
  • National Institutes of Health

Zitieren

APA

Lyu, M., & Sonnenberg, G. F. (2026). B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine. Journal of Experimental Medicine, 223(6). https://doi.org/10.1084/jem.20251094

Vancouver

Lyu M, Sonnenberg GF. B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine. Journal of Experimental Medicine. 2026;223(6). doi:10.1084/jem.20251094

BibTeX
@article{Lyu2026,
  author = {Lyu, Mengze and Sonnenberg, Gregory F},
  title = {B7 costimulation antagonizes RORγt+ regulatory T cells and immune tolerance in the intestine},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {6},
  doi = {10.1084/jem.20251094}
}
Kostenlos starten →